Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June.

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in ...

Medication abortions can be safely performed as early as the fourth week of pregnancy, researchers reported on Wednesday in ...

More than 9million prescriptions for Ozempic and similar weight loss drugs are written every year in the US, estimates ...

Novo Nordisk said on Monday (Nov 18) it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market. A spokesperson for the Danish drugmaker confirmed the ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...